Bjorck et al. [38] reported that patients with follicular lymphoma expressing higher level of Cyclin B1 showed better outcome after chemotherapy, compared to patients expressing lower level of Cyclin B1. The gene discussed is CCNB1; the disease is follicular lymphoma.